Archunan MW, Petronis S Bone Grafts in Trauma and Orthopaedics. Cureus. 2021 Sep 4;13(9):e17705. doi: 10.7759/cureus.17705. eCollection 2021 Sep.
Benedetti MG, et al Prot. CHILD-DEROT. 'Studio pilota per la pianificazione del trattamento alterazioni torsionali dell'arto inferiore nei bambini affetti da paralisi cerebrale infantile mediante valutazione integrata morfologica e funzionale.' CE AVEC 718/2021/Oss/IOR. 30/09/2021.
Dorsey ER The new platforms of health care. NPJ Digit Med. 2021 Jul 15;4(1):112. doi: 10.1038/s41746-021-00478-5.
F Osti et al., "CT conversion workflow for intraoperative usage of bony models: From DICOM data to 3D printed models," Applied Sciences (Switzerland), vol. 9, no. 4, Feb. 2019, doi: 10.3390/app9040708.
G Durastanti, C. Belvedere, M. Ruggeri, D. M. Donati, B. Spazzoli, and A. Leardini, "A Pelvic Reconstruction Procedure for Custom-Made Prosthesis Design of Bone Tumor Surgical Treatments," Applied Sciences 2022, Vol. 12, Page 1654, vol. 12, no. 3, p. 1654, Feb. 2022, doi: 10.3390/APP12031654.
G Pravettoni and S. Triberti, "A 'P5' Approach to Healthcare and Health Technology," P5 eHealth: An Agenda for the Health Technologies of the Future, pp. 3-17, 2020, doi: 10.1007/978-3-030-27994-3_1.
L Frizziero et al., "An innovative and cost-advantage cad solution for cubitus varus surgical planning in children," Applied Sciences (Switzerland), vol. 11, no. 9, May 2021, doi: 10.3390/app11094057.
L Frizziero et al., "Computer-aided surgical simulation for correcting complex limb deformities in children," Applied Sciences (Switzerland), vol. 10, no. 15, Aug. 2020, doi: 10.3390/app10155181.
L Frizziero et al., "Effectiveness assessment of CAD simulation in complex orthopedic surgery practices," Symmetry (Basel), vol. 13, no. 5, May 2021, doi: 10.3390/sym13050850.
L Frizziero et al., "New Methodology for Diagnosis of Orthopedic Diseases through Additive Manufacturing Models," Symmetry 2019, Vol. 11, Page 542, vol. 11, no. 4, p. 542, Apr. 2019, doi: 10.3390/SYM11040542.
L Frizziero et al., "Paediatric orthopaedic surgery with 3D printing: Improvements and cost reduction," Symmetry (Basel), vol. 11, no. 10, Oct. 2019, doi: 10.3390/sym11101317.
R Michaels et al., "3D printing in surgical simulation: emphasized importance in the COVID-19 pandemic era," https://doi.org/10.2217/3dp-2021-0009, vol. 5, no. 1, pp. 5-9, May 2021, doi: 10.2217/3DP-2021-0009.
Raza M, Murphy D, Gelfer Y The effect of three-dimensional (3D) printing on quantitative and qualitative outcomes in paediatric orthopaedic osteotomies: a systematic review. EFORT Open Rev. 2021 Feb 1;6(2):130-138. doi: 10.1302/2058-5241.6.200092. eCollection 2021 Feb.
S Dash, S. K. Shakyawar, M. Sharma, and S. Kaushik, "Big data in healthcare: management, analysis and future prospects," J Big Data, vol. 6, no. 1, pp. 1-25, Dec. 2019, doi: 10.1186/S40537-019-0217-0/FIGURES/6.
Vivarelli L, Govoni M, Attala D, Zoccali C, Biagini R, Dallari D Custom Massive Allograft in a Case of Pelvic Bone Tumour: Simulation of Processing with Computerised Numerical Control vs. Robotic Machining. J Clin Med. 2022 May 15;11(10):2781. doi: 10.3390/jcm11102781.
Advanced Surgical Simulation Processes in the Correction of Skeletal Defects and Deformities
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.